Physician Assistant Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Erin Herhold

Physician Assistant, Surgical Erie, PA Physician Assistant

NPI 1831438985 CMS profile 10988492

240 W 11Th St Ste 2, Erie, PA 16501

Open in the dashboard

General payments

$4,724

293 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Erin Herhold of Erie, PA is reported in the CMS Open Payments database as having received $4,724 across 293 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $93 5
2023 General $480 30
2022 General $1,419 102
2021 General $2,732 156

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Erin Herhold
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Erin Herhold were reported at $0. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Erin Herhold Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $2,732 $111 $36–$285 $132
2022 $1,419 $126 $44–$350 $149
2023 $480 $137 $47–$355 $160
2024 $93 $146 $49–$384 $164
2025 $0 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. Novo Nordisk Inc $1,476 73 payments
  2. Dexcom, Inc. $530 46 payments
  3. Lilly USA, LLC $478 32 payments
  4. AstraZeneca Pharmaceuticals LP $440 28 payments
  5. AbbVie, Inc. $265 15 payments
  6. Amarin Pharma Inc. $214 14 payments
  7. Bayer HealthCare Pharmaceuticals Inc. $201 13 payments
  8. Merck Sharp & Dohme Corporation $185 11 payments
  9. Sanofi-Aventis U.S. LLC $115 8 payments
  10. Amneal Pharmaceuticals LLC $83 5 payments
  11. Other $736 48 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Food and Beverage $4,713 292 payments
  2. Education $12 1 payment
Products named General payments · program years 2021–2024
  1. Ozempic $619 30 payments
  2. Dexcom G6 Transmitter $512 45 payments
  3. RYBELSUS $482 28 payments
  4. FARXIGA $440 28 payments
  5. Vascepa $214 14 payments
  6. Kerendia $201 13 payments
  7. BAQSIMI $185 14 payments
  8. STEGLATRO $185 11 payments
  9. Norditropin $134 8 payments
  10. LUPRON DEPOT $131 8 payments
  11. Other $2,251 138 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

293 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Surgical in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record